Recent Analyst Forecasts and Stock Ratings
Zevra Therapeutics, Inc. FAQ's
Zevra Therapeutics, Inc. has been rated by research analysts at Cantor Fitzgerald, Canaccord Genuity, Guggenheim, JMP Securities, Roth Capital, Maxim Group in the past 90 days.